What is Kymera Therapeutics's current debt?

Kymera Therapeutics (KYMR) reported current debt of $1.7M in Q1 2026.

How has Kymera Therapeutics's current debt changed year-over-year?

Kymera Therapeutics's current debt increased by 9.1% year-over-year, from $1.56M to $1.7M.

What is the long-term trend for Kymera Therapeutics's current debt?

Over 5 years (2020 to 2025), Kymera Therapeutics's current debt has grown at a 21.4% compound annual growth rate (CAGR), from $689K to $1.82M.

What does current debt mean?

The portion of long-term debt maturing within the next 12 months, requiring refinancing or repayment from operating cash flows.

Kymera Therapeutics KYMR Current Debt

Current Debt at other companies

PfizerPFE

$3.86B+3.0%

Johnson & JohnsonJNJ

$17.46B+25.6%

IncyteINCY

$4.41M-1.5%

Eli LillyLLY

$4B-0.4%

Gilead SciencesGILD

$1.31B-53.2%

ImmunityBio, Inc.IBRX

——

Other financials

Income statement

See full

Revenue$34.4M+55.5%

Operating income-$84.2M-13.1%

Net income-$69.2M-5.6%

EPS (diluted)-$0.71+13.4%

Balance sheet

See full

Cash & equivalents$144.1M+60.2%

Total debt$82.2M-6.5%

Total equity$1.5B+95.8%

Total assets$1.7B+81.7%

Cash flow

See full

Operating cash flow-$88.8M-12.2%

CapEx$434.0K-7.1%

Free cash flow-$89.3M-12.1%

Valuation

See full

Market cap$7.44B+283%

Enterprise value$7.38B+280%

P/S144.5×+111×

Profitability

See full

Operating margin-697.7%+635pp

Net margin-612%+602pp

FCF margin-474%+92.4pp

Returns & leverage

See full

Return on equity-27.1%-3.7pp

Debt / equity0.1×-0.1×

Current ratio10.8×+2.3×

Where this comes from

Reported directly by Kymera Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:FinanceLeaseLiabilityCurrent.

The official record: Kymera Therapeutics’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Kymera Therapeutics's current debt.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Kymera Therapeutics's current debt?: Kymera Therapeutics (KYMR) reported current debt of $1.7M in Q1 2026.
How has Kymera Therapeutics's current debt changed year-over-year?: Kymera Therapeutics's current debt increased by 9.1% year-over-year, from $1.56M to $1.7M.
What is the long-term trend for Kymera Therapeutics's current debt?: Over 5 years (2020 to 2025), Kymera Therapeutics's current debt has grown at a 21.4% compound annual growth rate (CAGR), from $689K to $1.82M.
What does current debt mean?: The portion of long-term debt maturing within the next 12 months, requiring refinancing or repayment from operating cash flows.